Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Mossman, D. Articles by Lehrer, D. S. Search for Related Content PubMed Citation Articles by Mossman, D. Articles by Lehrer, D. S. Quality of Care, Practice Guidelines Atypical Neuroleptics Conventional Neuroleptics

Conventional and Atypical Antipsychotics and the Evolving Standard of Care

Novel or atypical antipsychotic medications appear to offer patients the benefits of conventional neuroleptics with lower risks of side effects, but the newer drugs cost much more than the older drugs. Many U.S. psychiatrists have concluded that the novel antipsychotic drugs should be first-line therapy and represent an emerging standard of care in treating psychoses. This view raises the question of whether doctors who prescribe the older, cheaper drugs are engaging in malpractice or violating patients' rights. The authors explore reasons why psychiatrists may continue treating some psychotic patients with conventional neuroleptics, despite the apparent advantages of novel antipsychotics. They also describe possible sources of liability that might arise from using conventional neuroleptics and examine how existing case law might bear on these matters. Recent data on antipsychotic prescription practices and court decisions issued through September 2000 suggest that proper use of the older drugs is not a deviation from the standard of care. However, case law suggests that psychiatrists have a legal obligation to tell patients about novel antipsychotic agents even if they continue to prescribe conventional neuroleptics.

This article has been cited by other articles:

				N. R. Pinninti, B. Shaila, and G. Kumar Racial Bias in the Prescription Atypical of Antipsychotics? Psychiatr Serv, January 1, 2003; 54(1): 110 - 110. [Full Text] [PDF]

				G. Koren, T. Cohn, D. Chitayat, B. Kapur, G. Remington, D. M. Reid, and R. B. Zipursky Use of Atypical Antipsychotics During Pregnancy and the Risk of Neural Tube Defects in Infants Am J Psychiatry, January 1, 2002; 159(1): 136 - 137. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us